Marlborough-based Hologic, a medical technology firm specializing in women’s health, has entered into a partnership with international pharmaceutical firm Bayer to provide enhanced imaging mammogram ...
Retrospective analysis at top-tier medical facility highlights AI solution’s ability to help spot previously missed cancers and correctly localize suspicious areas on mammograms MARLBOROUGH, ...
MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic Inc. (Nasdaq: HOLX) and Bayer today announced an international partnership to deliver contrast-enhanced mammography (CEM) solutions to improve the ...
Bayer and Hologic have teamed up with the goal of offering clearer breast cancer scans as a package deal—combining the former’s imaging contrast agents with the latter’s mammography hardware. The two ...
Studies demonstrate AI’s potential to streamline radiologists’ workflows while upholding high sensitivity in detecting cancer MARLBOROUGH, Mass.--(BUSINESS WIRE)-- New data on Hologic’s (Nasdaq: HOLX) ...
Hologic has put forward more data bolstering the use of its artificial intelligence programs for detecting breast cancer through mammography. The study, conducted at Massachusetts General Hospital and ...
New research on Hologic's AI-driven breast cancer detection technologies, including a study focused on invasive lobular cancer, was presented at the Society of Breast Imaging (SBI) Symposium over the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results